HealthEquity (HQY) Reports In-Line Q1 EPS, Raises FY Revenue Guidance
HealthEquity (NASDAQ: HQY) reported Q1 EPS of $0.09, in-line with the analyst estimate of $0.09. Revenue for the quarter came in at $29.9 million versus the consensus estimate of $28.65 million.
HealthEquity sees FY2016 EPS of $0.28-$0.30, versus the consensus of $0.30. HealthEquity sees FY2016 revenue of $119-123 million, versus prior guidance of $117-121 million and the consensus of $120.50 million.
For earnings history and earnings-related data on HealthEquity (HQY) click here.
